• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异基因PrLZ的转录变体及其与14-3-3蛋白的相互作用。

Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins.

作者信息

Wang Ruoxiang, He Hui, Sun Xiaojuan, Xu Jianchun, Marshall Fray F, Zhau Haiyen, Chung Leland W K, Fu Haian, He Dalin

机构信息

Department of Urology, Emory University School of Medicine, Atlanta, GA 30322, USA.

出版信息

Biochem Biophys Res Commun. 2009 Nov 20;389(3):455-60. doi: 10.1016/j.bbrc.2009.08.165. Epub 2009 Sep 2.

DOI:10.1016/j.bbrc.2009.08.165
PMID:19732746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3311924/
Abstract

We have reported isolation and characterization of the prostate-specific and androgen-regulated PrLZ gene abnormally expressed in prostate cancer. PrLZ is a potential biomarker for prostate cancer and a candidate oncogene promoting cell proliferation and survival in prostate cancer cells. A full delineation of the PrLZ gene and its gene products may provide clues to the mechanisms regulating its expression and function. In this report, we identified three additional exons in the PrLZ gene and recognized five transcript variants from alternative splicing that could be detected by RT-PCR and Western blotting. Structural comparison demonstrated that the PrLZ proteins are highly conserved among species. PrLZ contains multiple potential sites for interaction with other proteins. We used mammalian two-hybrid assays to demonstrate that PrLZ isoforms interact with 14-3-3 proteins, and multiple sites in the PrLZ may be involved in the interaction. Alternative splicing may contribute to abnormally enhanced PrLZ levels in prostate cancer, and interaction with 14-3-3 proteins may be a mechanism by which PrLZ promotes cell proliferation and survival during prostate cancer development and progression. This information is a valuable addition to the investigation of the oncogenic properties of the PrLZ gene.

摘要

我们已报道了在前列腺癌中异常表达的前列腺特异性且受雄激素调节的PrLZ基因的分离与特性分析。PrLZ是前列腺癌的潜在生物标志物以及促进前列腺癌细胞增殖和存活的候选癌基因。对PrLZ基因及其基因产物的全面描述可能为调节其表达和功能的机制提供线索。在本报告中,我们在PrLZ基因中鉴定出另外三个外显子,并识别出五个通过逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法(Western blotting)可检测到的可变剪接转录变体。结构比较表明,PrLZ蛋白在物种间高度保守。PrLZ包含多个与其他蛋白质相互作用的潜在位点。我们使用哺乳动物双杂交试验证明PrLZ同工型与14-3-3蛋白相互作用,并且PrLZ中的多个位点可能参与这种相互作用。可变剪接可能导致前列腺癌中PrLZ水平异常升高,与14-3-3蛋白的相互作用可能是PrLZ在前列腺癌发生和发展过程中促进细胞增殖和存活的一种机制。该信息是对PrLZ基因致癌特性研究的有价值补充。

相似文献

1
Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins.前列腺特异基因PrLZ的转录变体及其与14-3-3蛋白的相互作用。
Biochem Biophys Res Commun. 2009 Nov 20;389(3):455-60. doi: 10.1016/j.bbrc.2009.08.165. Epub 2009 Sep 2.
2
PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.PrLZ 通过激活 Stat3/Bcl-2 通路保护前列腺癌细胞免受雄激素剥夺诱导的细胞凋亡。
Cancer Res. 2011 Mar 15;71(6):2193-202. doi: 10.1158/0008-5472.CAN-10-1791. Epub 2011 Mar 8.
3
PrLZ is expressed in normal prostate development and in human prostate cancer progression.PrLZ在正常前列腺发育和人类前列腺癌进展过程中均有表达。
Clin Cancer Res. 2007 Oct 15;13(20):6040-8. doi: 10.1158/1078-0432.CCR-07-0640.
4
PrLZ expression is associated with the progression of prostate cancer LNCaP cells.PrLZ表达与前列腺癌LNCaP细胞的进展相关。
Mol Carcinog. 2009 May;48(5):432-40. doi: 10.1002/mc.20481.
5
ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression.ERK1/2 抑制 Cullin 3/SPOP 介导的 PrLZ 泛素化和降解,从而调节前列腺癌的进展。
Cell Death Differ. 2022 Aug;29(8):1611-1624. doi: 10.1038/s41418-022-00951-y. Epub 2022 Feb 22.
6
Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.PrLZ 介导的雄激素受体反式激活促进去势抵抗阶段前列腺癌的生长。
Carcinogenesis. 2013 Feb;34(2):257-67. doi: 10.1093/carcin/bgs337. Epub 2012 Oct 26.
7
PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.PrLZ 通过抑制 LKB1/AMPK 介导的自噬增加前列腺癌多西他赛耐药性。
Theranostics. 2018 Jan 1;8(1):109-123. doi: 10.7150/thno.20356. eCollection 2018.
8
PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.PrLZ是TPD52家族中一个新的前列腺特异性且雄激素应答基因,在染色体8q21.1上扩增并在人类前列腺癌中过表达。
Cancer Res. 2004 Mar 1;64(5):1589-94. doi: 10.1158/0008-5472.can-03-3331.
9
Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.miR-449a 缺失导致 PrLZ 过表达促进前列腺癌转移。
Int J Oncol. 2017 Aug;51(2):435-444. doi: 10.3892/ijo.2017.4038. Epub 2017 Jun 12.
10
[Impact of PrLZ overexpression on invasion of prostate cancer LNCaP cells in vitro].[PRLZ过表达对前列腺癌LNCaP细胞体外侵袭的影响]
Ai Zheng. 2009 May;28(5):483-6.

引用本文的文献

1
DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk.苯甲酸雌二醇和双酚A引起的DNA甲基化组变化将早期环境暴露与前列腺癌风险联系起来。
Epigenetics. 2016 Sep;11(9):674-689. doi: 10.1080/15592294.2016.1208891. Epub 2016 Jul 14.
2
Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.TPD52的亚型1(PC-1)促进前列腺癌细胞的神经内分泌转分化。
Tumour Biol. 2016 Aug;37(8):10435-46. doi: 10.1007/s13277-016-4925-1. Epub 2016 Feb 5.
3
PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.PC-1/PrLZ通过增强4E-BP1的稳定性赋予前列腺癌细胞对雷帕霉素的抗性。
Oncotarget. 2015 Aug 21;6(24):20356-69. doi: 10.18632/oncotarget.3931.
4
Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.肿瘤蛋白 D54 是口腔鳞状细胞癌细胞系中细胞外基质依赖的迁移和黏附的负调节剂。
Cell Oncol (Dordr). 2013 Jun;36(3):233-45. doi: 10.1007/s13402-013-0131-y. Epub 2013 Mar 26.
5
Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.PrLZ 介导的雄激素受体反式激活促进去势抵抗阶段前列腺癌的生长。
Carcinogenesis. 2013 Feb;34(2):257-67. doi: 10.1093/carcin/bgs337. Epub 2012 Oct 26.

本文引用的文献

1
Alternative splicing and biological heterogeneity in prostate cancer.前列腺癌中的可变剪接和生物学异质性。
Nat Rev Urol. 2009 Aug;6(8):454-60. doi: 10.1038/nrurol.2009.125.
2
Quantitative regulation of alternative splicing in evolution and development.进化与发育过程中可变剪接的定量调控
Bioessays. 2009 Jan;31(1):40-50. doi: 10.1002/bies.080092.
3
Alternative splicing and disease.可变剪接与疾病
Biochim Biophys Acta. 2009 Jan;1792(1):14-26. doi: 10.1016/j.bbadis.2008.09.017. Epub 2008 Oct 17.
4
PrLZ is expressed in normal prostate development and in human prostate cancer progression.PrLZ在正常前列腺发育和人类前列腺癌进展过程中均有表达。
Clin Cancer Res. 2007 Oct 15;13(20):6040-8. doi: 10.1158/1078-0432.CCR-07-0640.
5
The impact of alternative splicing in vivo: mouse models show the way.可变剪接在体内的影响:小鼠模型指明方向。
RNA. 2007 Aug;13(8):1155-71. doi: 10.1261/rna.554607. Epub 2007 Jun 11.
6
Epigenetic silencing of 14-3-3sigma in cancer.癌症中14-3-3σ的表观遗传沉默
Semin Cancer Biol. 2006 Jun;16(3):214-24. doi: 10.1016/j.semcancer.2006.03.008. Epub 2006 Apr 1.
7
Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.14-3-3σ在乳腺癌和前列腺癌中的表观遗传和蛋白水解失活
Semin Cancer Biol. 2006 Jun;16(3):235-9. doi: 10.1016/j.semcancer.2006.03.006. Epub 2006 Apr 1.
8
Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.一种前列腺特异性且与前列腺癌相关的非编码基因PCGEM1对细胞凋亡的调控
DNA Cell Biol. 2006 Mar;25(3):135-41. doi: 10.1089/dna.2006.25.135.
9
D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells.D53(TPD52L1)是一种细胞周期调控蛋白,在乳腺癌细胞的G2-M期转换时表达量最高。
Exp Cell Res. 2005 Oct 15;310(1):152-65. doi: 10.1016/j.yexcr.2005.07.009.
10
Expression of genes and proteins specific for prostate cancer.前列腺癌特异性基因和蛋白质的表达。
J Urol. 2004 Nov;172(5 Pt 2):S23-6; discussion S26-7. doi: 10.1097/01.ju.0000141781.70474.48.